Petrus Trust Company’s ResMed RMD Stock Holding History

Petrus Trust Company’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,144	Closed	-$256K	–	687
2025 Q1	$256K	Buy	+1,144	New	+$267K	0.02%	456
2024 Q4	–	Sell	-1,231	Closed	-$301K	–	718
2024 Q3	$301K	Sell	1,231 -339	-22%	-$75.8K	0.03%	408
2024 Q2	$301K	Buy	+1,570	New	+$319K	0.03%	435
2023 Q3	–	Sell	-2,416	Closed	-$528K	–	705
2023 Q2	$528K	Buy	2,416 +1,406	+139%	+$313K	0.06%	133
2023 Q1	$221K	Sell	1,010 -1,000	-50%	-$217K	0.03%	438
2022 Q4	$418K	Buy	+2,010	New	+$442K	0.05%	146
2020 Q1	–	Sell	-1,431	Closed	-$222K	–	299
2019 Q4	$222K	Buy	+1,431	New	+$206K	0.04%	224

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Petrus Trust Company's RMD Position: Q2 2025 in Review

Petrus Trust Company sold out of ResMed (RMD) in Q2 2025, closing a stake of 1,144 shares — an estimated $256K sold.

Petrus Trust Company first reported a position in RMD in Q4 2019 and held it in 7 quarters. The position peaked at $528K in Q2 2023. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

Petrus Trust Company reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
Petrus Trust Company sold 1,144 ResMed shares in Q2 2025, an estimated $256K.
Petrus Trust Company first reported a position in ResMed in Q4 2019 and held it in 7 quarters.
Petrus Trust Company's ResMed position peaked at $528K in Q2 2023.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Petrus Trust Company's 13F filing for Q2 2025, filed 14 Aug 2025.